Skip to main content
After having completed a Knowledge Transfer Partnership in collaboration with Argentium Ltd UK in Surface Chemistry, I then went on to complete a PhD in Organic Chemistry in 2016 at Kingston University. During the PhD the synthesis and characterisation of thiophene based dendrimers used for encapsulation was investigated. The versatility of these dendrimers and their properties to be used as labels for antibody diagnostic reagents further sparked my interest in exploring research opportunities in industry.
Throughout my 5 years in industry I gained expertise in the research and development of bioconjugate synthesis and purification, ranging from labelling of antibodies with UV active/fluorescent probes, drugs, dendrimers/macromolecules/polymers, latex and polystyrene beads or other proteins to immunogen synthesis. This, in combination with my background in organic/material chemistry, led to an interest in the synthesis or modification of small molecules, e.g. drugs for antibody drug conjugates (ADC), UV active labels for detection and larger molecules, e.g. dendrimers, amino-dextran for either carrier or scaffold structures attached to antibodies for use in the pharmaceutical industry.
I was appointed as a lecturer in Pharmaceutical Science in 2020 and have lead on designing modules with up to date knowledge in the area of bioconjugation. I bridge the gap between research and industry through embedding "Future Skills" of working in ISO9001/13485 accredited laboratories in modules delivered to postgraduate and undergraduate students. My research expertise lies within bioconjugation and organic chemistry.
Senior Lecturer in Pharmaceutical Science
After obtaining my PhD in organic/materials chemistry, titled "The Synthesis and Properties of Phenyl-Cored Thiophene Dendrimers" I quickly gained the position of Senior Chemist in a biotechnology company. Where I utilised my undergraduate biological experience and research expertise in the synthesis of organic/macromolecule compounds to aid in the development of bioconjugates for antibody drug conjugates (ADC), anti-drug antibodies (ADA) and in-vitro diagnostics, e.g. lateral flow assay development, for a wide range of pharmaceutical and bio-pharmaceutical research.